MedPath

Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical Relevance

Conditions
Severe Sepsis and Septic Shock
Registration Number
NCT02391792
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Microparticules (MPs) result from plasma cell membrane remodeling and shedding after cell stimulation or apoptosis. MPs are know recognized as a pool of bioactive messengers with merging role in pathophysiology of immune and cardiovascular diseases. MPs have been characterized during septic shock and may contribute to dissemination of pro-inflammatory and procoagulant mediators. This a prospective observational study of circulating MPs and blood coagulation in septic shock patients admitted in medical intensive care units (ICUs) of four tertiary hospitals at baseline (D1, D2, D3, D4, D7).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Septic shock (patients)
  • Without septic shock (control)
  • Informed consent
Exclusion Criteria
  • Class IV heart failure
  • Child-plugh grade C cirrhosis
  • Cancer under active treatment
  • BMI>35kg/m2
  • Moribund patient
  • DNR decision

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change from baseline in number and type of circulating microparticles at 7 daysBaseline and 7 days
Change from baseline in blood coagulation markers at 7 daysBaseline and 7 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nouvel Hopital Civil

🇫🇷

Strasbourg, Alsace, France

© Copyright 2025. All Rights Reserved by MedPath